Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2857)
All Articles published online
|
May 7, 2005 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ding X, Yang LY, Huang GW, Yang JQ, Liu HL, Wang W, Peng JX, Yang JQ, Tao YM, Chang ZG, Ling XS. Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: A systematic review and meta-analysis. World J Gastroenterol 2005; 11(17): 2656-2661 [PMID: 15849829 DOI: 10.3748/wjg.v11.i17.2656] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i17/2656.htm |
| Number | Citing Articles |
| 1 |
Tara Behne, M. Sitki Copur. Biomarkers for Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/859076
|
| 2 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
| 3 |
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
|
| 4 |
Alvarado-Noguez Margarita Lizeth, Blas-Valdivia Vanessa, Thompson-Bonilla María del Rocio, Franco-Colín Margarita, Jacinto-Méndez Damián, Cruz-Orea Alfredo, Cano-Europa Edgar, Rojas-Franco Placido. Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy. Applied Spectroscopy 2024; 78(3): 296 doi: 10.1177/00037028231222508
|
| 5 |
Yuqing Zhang, Tianqiang Song, Lingxin Meng, Xiongzhi Wu, Yi Ba, Qiang Li. Melanoma antigen‐1 mRNA combined with α‐fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?. ANZ Journal of Surgery 2009; 79(1-2): 62 doi: 10.1111/j.1445-2197.2008.04801.x
|
| 6 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 7 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|
| 8 |
Fabio Grizzi, Barbara Franceschini, Cody Hamrick, Eldo E Frezza, Everardo Cobos, Maurizio Chiriva-Internati. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-3
|
| 9 |
W. Song, H. Li, K. Tao, R. Li, Z. Song, Q. Zhao, F. Zhang, K. Dou. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. International Journal of Clinical Practice 2008; 62(8): 1212 doi: 10.1111/j.1742-1241.2008.01777.x
|
| 10 |
Jeng-Wei Lu, Jan-Gowth Chang, Kun-Tu Yeh, Rong-Ming Chen, Jeffrey J.P. Tsai, Rouh-Mei Hu. Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochemica 2011; 113(8): 833 doi: 10.1016/j.acthis.2011.01.001
|
| 11 |
Chen Zhong, Jin-Dao Wu, Ming-Ming Fang, Li-Yong Pu. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. Tumor Biology 2015; 36(10): 7623 doi: 10.1007/s13277-015-3487-y
|
| 12 |
Kun-Song Zhang, Qi Zhou, Ya-Feng Wang, Li-Jian Liang. Killing Effects of Different Physical Factors on Extracorporeal HepG2 Human Hepatoma Cells. Asian Pacific Journal of Cancer Prevention 2012; 13(3): 1025 doi: 10.7314/APJCP.2012.13.3.1025
|
| 13 |
Lian-Yue Yang, Yi-Ming Tao, Di-Peng Ou, Wei Wang, Zhi-Gang Chang, Fan Wu. Increased Expression of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein 2 Correlated with Poor Prognosis of Hepatocellular Carcinoma. Clinical Cancer Research 2006; 12(19): 5673 doi: 10.1158/1078-0432.CCR-06-0022
|
| 14 |
Asmaa I Gomaa, Shahid A Khan, Edward LS Leen, Imam Waked, Simon D Taylor-Robinson. Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(11): 1301-1314 doi: 10.3748/wjg.15.1301
|
| 15 |
Asako Kimura, Kazuyuki Sogawa, Mamoru Satoh, Yoshio Kodera, Osamu Yokosuka, Takeshi Tomonaga, Fumio Nomura. The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma. International Journal of Proteomics 2012; 2012: 1 doi: 10.1155/2012/623190
|
| 16 |
Yang Liu, Kazuyuki Sogawa, Masahiko Sunaga, Hiroshi Umemura, Mamoru Satoh, Takahiro Kazami, Masaharu Yoshikawa, Takeshi Tomonaga, Osamu Yokosuka, Fumio Nomura. Increased Concentrations of Apo A-I and Apo A-II Fragments in the Serum of Patients With Hepatocellular Carcinoma by Magnetic Beads–Assisted MALDI-TOF Mass Spectrometry. American Journal of Clinical Pathology 2014; 141(1): 52 doi: 10.1309/AJCPBLFBNAP6N2UN
|
| 17 |
Lorenzo Andreana, Graziella Isgrò, Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World Journal of Hepatology 2009; 1(1): 48-61 doi: 10.4254/wjh.v1.i1.48
|
| 18 |
P. Guéguen, C. Le Maréchal. Profil moléculaire des tumeurs hépatobiliaires: vers de nouvelles pistes, facteurs prédictifs et cibles thérapeutiques. Oncologie 2012; 14(3): 186 doi: 10.1007/s10269-012-2138-9
|